The Enterprise Value as of December 2025 (TTM) for Cytosorbents Corporation (CTSO) is 66.01M

According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 66.01M. This represents a change of -18.69% compared to the average of 81.18M of the last 4 quarters.

Cytosorbents Corporation (CTSO) Historical Enterprise Value (quarterly & annually)

How has CTSO Enterprise Value performed in the past?

The mean historical Enterprise Value of Cytosorbents Corporation over the last ten years is 138.09M. The current 66.01M Enterprise Value has changed 4.68% with respect to the historical average. Over the past ten years (40 quarters), CTSO's Enterprise Value was at its highest in in the September 2018 quarter at 380.71M. The Enterprise Value was at its lowest in in the September 2022 quarter at 50.10M.

Cytosorbents Corporation (CTSO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cytosorbents Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cytosorbents Corporation (CTSO) Average Enterprise Value

How has CTSO Enterprise Value performed in the past?

The current Enterprise Value of Cytosorbents Corporation (CTSO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cytosorbents Corporation (CTSO) Enterprise Value vs. Peers

How is CTSO’s Enterprise Value compared to its peers?

Cytosorbents Corporation’s Enterprise Value is greater than IceCure Medical Ltd (42.14M), greater than TELA Bio, Inc. (52.89M), greater than Spectral AI, Inc. (50.99M), greater than Sensus Healthcare, Inc. (42.11M), greater than NeuroOne Medical Technologies Corporation (25.76M), less than Baird Medical Investment Holdings Limited (78.24M), greater than electroCore, Inc. (40.18M), greater than Telomir Pharmaceuticals, Inc. Common Stock (39.43M), less than Biodesix, Inc. (119.25M), greater than Serina Therapeutics, Inc. (31.15M),

Build a custom stock screener for Cytosorbents Corporation (CTSO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytosorbents Corporation (CTSO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.